TY  - JOUR
AU  - Ribera, Josep-Maria
AU  - Garcia-Calduch, Olga
AU  - Ribera, Jordi
AU  - Montesinos, Pau
AU  - Cano-Ferri, Isabel
AU  - Martinez, Pilar
AU  - Esteve, Jordi
AU  - Esteban, Daniel
AU  - Garcia-Fortes, Maria
AU  - Alonso, Natalia
AU  - Gonzalez-Campos, Jose
AU  - Bermudez, Arancha
AU  - Torrent, Anna
AU  - Genesca, Eulalia
AU  - Mercadal, Santiago
AU  - Martinez-Lopez, Joaquin
AU  - Garcia-Sanz, Ramon
PY  - 2022
DO  - 10.1182/bloodadvances.2022007764
UR  - http://hdl.handle.net/10668/20253
T2  - Blood advances
AB  - Promising results have been shown with the combination of ponatinib and chemotherapy in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). The PONALFIL (Ponatinib With Chemotherapy for Young Adults Ph Positive Acute...
LA  - en
PB  - American Society of Hematology
KW  - Imatinib Mesylate
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Imidazoles
KW  - Precursor Cell Lymphoblastic Leukemia-Lymphoma
KW  - Young Adult
KW  - Disease-Free Survival
KW  - Humans
KW  - Middle Aged
KW  - Philadelphia Chromosome
KW  - Protein Kinase Inhibitors
KW  - Pyridazines
KW  - Recurrence
TI  - Ponatinib, chemotherapy, and transplant in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
TY  - research article
VL  - 6
ER  -